Company: FENC
Filing Date: 2025-03-10
Form Type: 8-K
Source: 0001558370-25-002599
Chunk: 0

Company: FENNEC PHARMACEUTICALS INC.
Filing Date: 2025-03-10
Form: 8-K
Item: Item 2.02
Chunk 0
---
Item 2.02.      Results of Operations and Financial Condition.  

On March 10, 2025, Fennec Pharmaceuticals Inc. issued a news release announcing full year and fourth quarter financial results for the period ended December 31, 2024. A copy of the news release is attached as Exhibit 99.1 to this Current Report on Form 8-K.

The information contained in this Current Report on Form 8-K, including the exhibit attached hereto, is being furnished and shall not be deemed to be filed for the purposes of Section 18 of the Securities Exchange Act of 1934 (the “ Exchange Act”), or incorporated by reference into any filing under the Securities Act of 1933 or the Exchange Act, unless such subsequent filing specifically references this Form 8-K.